Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of efficacy in slowing progression of...
Thursday 22 August 2024 9:23 am
Share
Facebook Share on Facebook
X Share on Twitter
LinkedIn Share on LinkedIn
WhatsApp Share on WhatsApp
Email Share on Email
A September rate cut looks nailed on after minutes...
What’s going on here?Germany's business activity shrank for the second consecutive month in August, with a deeper contraction than anticipated, according to Thursday’s preliminary...
Prior 43.2Services PMI 51.4 vs 52.3 expectedPrior 52.5Composite PMI 48.5 vs 49.2 expectedPrior 49.1German business activity continues to contract in August and the services...
Introduction: Pound at one-year high against weaker dollarGood morning, and welcome to our rolling coverage of business, the financial markets and the world economy.The...